Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 3
1967 13
1968 12
1969 7
1970 2
1971 3
1972 6
1973 6
1974 10
1975 10
1976 18
1977 23
1978 24
1979 32
1980 34
1981 30
1982 22
1983 14
1984 12
1985 26
1986 11
1987 12
1988 10
1989 19
1990 19
1991 16
1992 24
1993 17
1994 23
1995 23
1996 14
1997 29
1998 20
1999 18
2000 15
2001 22
2002 32
2003 32
2004 36
2005 49
2006 38
2007 46
2008 49
2009 40
2010 37
2011 44
2012 64
2013 87
2014 59
2015 54
2016 54
2017 45
2018 40
2019 50
2020 50
2021 42
2022 62
2023 67
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

1,552 results

Results by year

Filters applied: . Clear all
Page 1
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials.
Kimball AB, Jemec GBE, Alavi A, Reguiai Z, Gottlieb AB, Bechara FG, Paul C, Giamarellos Bourboulis EJ, Villani AP, Schwinn A, Ruëff F, Pillay Ramaya L, Reich A, Lobo I, Sinclair R, Passeron T, Martorell A, Mendes-Bastos P, Kokolakis G, Becherel PA, Wozniak MB, Martinez AL, Wei X, Uhlmann L, Passera A, Keefe D, Martin R, Field C, Chen L, Vandemeulebroecke M, Ravichandran S, Muscianisi E. Kimball AB, et al. Lancet. 2023 Mar 4;401(10378):747-761. doi: 10.1016/S0140-6736(23)00022-3. Epub 2023 Feb 3. Lancet. 2023. PMID: 36746171 Clinical Trial.
Adalimumab: a review of side effects.
Scheinfeld N. Scheinfeld N. Expert Opin Drug Saf. 2005 Jul;4(4):637-41. doi: 10.1517/14740338.4.4.637. Expert Opin Drug Saf. 2005. PMID: 16011443 Review.
Drug-induced diarrhoea.
[No authors listed] [No authors listed] Prescrire Int. 2017 Mar;26(180):67-71. Prescrire Int. 2017. PMID: 30730620 Review. No abstract available.
Drug-related lupus.
Hess EV. Hess EV. Curr Opin Rheumatol. 1991 Oct;3(5):809-14. doi: 10.1097/00002281-199110000-00010. Curr Opin Rheumatol. 1991. PMID: 1751313 Review.
An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.
Rao K, Zhao Q, Bell J, Krishnan J, Henig O, Daniel J, Sawaya K, Albin O, Mills JP, Petty LA, Gregg K, Kaul D, Malani AN, Pogue J, Kaye KS. Rao K, et al. Clin Infect Dis. 2024 Feb 17;78(2):277-282. doi: 10.1093/cid/ciad606. Clin Infect Dis. 2024. PMID: 37797310 Clinical Trial.
Drug-induced lupus.
Rubin RL. Rubin RL. Toxicology. 2005 Apr 15;209(2):135-47. doi: 10.1016/j.tox.2004.12.025. Toxicology. 2005. PMID: 15767026 Review.
Mycobacterial Infections Potentiated by Biologics.
Calabrese C, Winthrop KL. Calabrese C, et al. Infect Dis Clin North Am. 2020 Jun;34(2):413-423. doi: 10.1016/j.idc.2020.02.011. Infect Dis Clin North Am. 2020. PMID: 32444014 Review.
1,552 results